Metformin is a biguanide and is the only one in this class registered for use for Australia.
Metformin is an insulin sensitiser and does not cause hypoglycaemia as a side effect. It is one of the few diabetes medicines that will continued to be prescribed once insulin is initiated to keep the prescribed dose of insulin as low as practicable.